JP2003510359A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510359A5
JP2003510359A5 JP2001527795A JP2001527795A JP2003510359A5 JP 2003510359 A5 JP2003510359 A5 JP 2003510359A5 JP 2001527795 A JP2001527795 A JP 2001527795A JP 2001527795 A JP2001527795 A JP 2001527795A JP 2003510359 A5 JP2003510359 A5 JP 2003510359A5
Authority
JP
Japan
Prior art keywords
anilino
triazole
methyl
benzylthio
ylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001527795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510359A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/026951 external-priority patent/WO2001024796A1/en
Publication of JP2003510359A publication Critical patent/JP2003510359A/ja
Publication of JP2003510359A5 publication Critical patent/JP2003510359A5/ja
Pending legal-status Critical Current

Links

JP2001527795A 1999-10-01 2000-09-29 化合物および方法 Pending JP2003510359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15728699P 1999-10-01 1999-10-01
US60/157,286 1999-10-01
PCT/US2000/026951 WO2001024796A1 (en) 1999-10-01 2000-09-29 1,2,4-triazole derivatives, composition, process of making and methods of use

Publications (2)

Publication Number Publication Date
JP2003510359A JP2003510359A (ja) 2003-03-18
JP2003510359A5 true JP2003510359A5 (enExample) 2007-11-22

Family

ID=22563095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001527795A Pending JP2003510359A (ja) 1999-10-01 2000-09-29 化合物および方法

Country Status (5)

Country Link
US (1) US7304082B2 (enExample)
EP (1) EP1223932A4 (enExample)
JP (1) JP2003510359A (enExample)
AU (1) AU7989400A (enExample)
WO (1) WO2001024796A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002078697A1 (en) * 2001-03-29 2002-10-10 Smithkline Beecham Corporation Compounds and methods
WO2003083068A2 (en) * 2002-03-27 2003-10-09 Smithkline Beecham Corporation Compounds and methods
AR040847A1 (es) * 2002-08-09 2005-04-20 Astrazeneca Ab 1,2,4-oxadiazoles como moduladores de receptores de glutamato metabotropicos, para el tratamiento de desordenes neurologicos y psiquiatricos
FR2862060A1 (fr) * 2003-11-06 2005-05-13 Galderma Res & Dev Procede de synthese en phase solide de composes de types sulfures de diaryle.
AU2007267803B2 (en) * 2006-05-25 2011-08-25 Synta Pharmaceuticals Corp. Method for treating non-Hodgkin's lymphoma
WO2009003110A2 (en) 2007-06-26 2008-12-31 Children's Medical Center Corporation Metap-2 inhibitor polymersomes for therapeutic administration
EP2486004B1 (en) 2009-10-09 2017-05-03 Zafgen, Inc. Sulphone compounds for use in the treatment of obesity
US8815309B2 (en) 2010-01-08 2014-08-26 Zafgen, Inc. Methods of treating a subject with benign prostate hyperplasia
US20130023513A1 (en) 2010-01-12 2013-01-24 Hughes Thomas E Methods and Compositions for Treating Cardiovascular Disorders
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
EP2560640A1 (en) 2010-04-19 2013-02-27 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
CN103249735B (zh) * 2010-07-22 2016-04-06 扎夫根股份有限公司 三环化合物及其制备和使用方法
US20140073691A1 (en) 2010-11-10 2014-03-13 Zafgen, Inc. Methods and composition for Treating Thyroid Hormone Related Disorders
US20130316994A1 (en) 2010-11-29 2013-11-28 Zafgen, Inc. Methods of Reducing Risk of Hepatobiliary Dysfunction During Rapid Weight Loss with METAP-2 Inhibitors
US9189078B2 (en) 2010-12-20 2015-11-17 Apple Inc. Enhancing keycap legend visibility with optical components
KR20140006888A (ko) 2011-01-26 2014-01-16 자프겐 인크. 테트라졸화합물, 그리고, 이를 제조하는 방법 및 이를 이용하는 방법
CA2835261C (en) 2011-05-06 2019-06-04 Zafgen, Inc. Partially saturated tricyclic compounds and methods of making and using same
AU2012253759B2 (en) 2011-05-06 2016-01-21 Zafgen Inc. Tricyclic sulfonamide compounds and methods of making and using same
BR112013028666A2 (pt) 2011-05-06 2017-08-08 Zafgen Inc compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo
EP2763671A2 (en) 2011-10-03 2014-08-13 Zafgen, Inc. Methods of treating age related disorders
WO2013067162A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
JP2014534228A (ja) 2011-11-02 2014-12-18 シンタ ファーマシューティカルズ コーポレーション 白金含有剤とhsp90阻害剤の組合せ療法
EP2780010A1 (en) 2011-11-14 2014-09-24 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with braf inhibitors
MX2014008706A (es) 2012-01-18 2015-03-05 Zafgen Inc Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
JP2015509102A (ja) 2012-01-18 2015-03-26 ザフゲン,インコーポレイテッド 三環式スルホン化合物並びにその作製および使用方法
AU2013259617A1 (en) 2012-05-08 2014-11-27 Zafgen, Inc. Treating hypothalamic obesity with MetAP2 inhibitors
MX356755B (es) 2012-05-09 2018-06-11 Zafgen Inc Compuestos de tipo fumagilol y metodos para su elaboración y uso.
NZ707773A (en) 2012-11-05 2019-05-31 Zafgen Inc Methods of treating liver diseases
JP2015536981A (ja) 2012-11-05 2015-12-24 ザフゲン,インコーポレイテッド 三環式化合物ならびにその製造および使用方法
BR112015010223A2 (pt) 2012-11-05 2017-07-11 Zafgen Inc compostos tricíclicos para o uso no tratamento e/ou controle de obesidade
CN105228610A (zh) 2013-03-14 2016-01-06 扎夫根股份有限公司 治疗肾疾病和其它病症的方法
WO2015089800A1 (en) 2013-12-19 2015-06-25 Eli Lilly And Company Fluorophenyl pyrazol compounds
EP3154634B1 (en) * 2014-06-12 2021-02-24 Université de Lille Imidazol- or 1,2,4-triazol-derivatives and their use
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
MA52489A (fr) * 2018-05-04 2021-03-10 Inflazome Ltd Nouveaux composés

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120571A (en) * 1979-03-02 1980-09-17 Glaxo Group Ltd Heterocyclic derivative
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
HU191475B (en) * 1982-09-01 1987-02-27 Gyogyszerkutato Intezet Process for producing new acylized 1,2,4-triazole derivatives
US4760448A (en) * 1987-05-04 1988-07-26 Sencore, Inc. Method of measuring amplitude variations of a video carrier and apparatus therefor
JPH01160972A (ja) * 1987-12-18 1989-06-23 Tsumura & Co 1,2,4−トリアゾール誘導体及びそれを有効成分として含有する抗潰瘍剤
DE4142366A1 (de) 1991-07-15 1993-06-24 Thomae Gmbh Dr K Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9207396D0 (en) 1992-04-03 1992-05-13 Merck Sharp & Dohme Therapeutic agents
DE4424787A1 (de) 1994-07-14 1996-01-18 Bayer Ag Substituierte Aryliminoheterocyclen
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
WO1996016971A1 (de) * 1994-11-29 1996-06-06 Lonza Ag Verfahren zur herstellung optisch aktiver metallocenylphosphine
US5798374A (en) * 1995-06-07 1998-08-25 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
US6207704B1 (en) * 1997-06-09 2001-03-27 Massachusetts Institute Of Technology Type 2 methionine aminopeptidase [MetAP2] inhibitors and uses thereof
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
DE19921567A1 (de) * 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
WO2001036404A1 (en) 1999-11-19 2001-05-25 Smithkline Beecham Corporation Compounds and methods
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
AU2001231154A1 (en) * 2000-01-24 2001-07-31 Adherex Technologies Inc. Peptidomimetic modulators of cell adhesion
AU2001253418A1 (en) * 2000-04-12 2001-10-30 Smith Kline Beecham Corporation Compounds and methods
WO2002005804A1 (en) 2000-07-19 2002-01-24 Smithkline Beecham Corporation Compounds and methods
JP2005506299A (ja) * 2001-03-29 2005-03-03 スミスクライン・ビーチャム・コーポレイション 化合物および方法
JP2004525942A (ja) * 2001-03-29 2004-08-26 スミスクライン・ビーチャム・コーポレイション 化合物および方法
JP2004535377A (ja) 2001-04-03 2004-11-25 スミスクライン・ビーチャム・コーポレイション Metap2を阻害する方法
WO2003031434A1 (en) * 2001-10-12 2003-04-17 Smith Kline Beecham Corporation Compounds and methods
AU2002359694A1 (en) 2001-12-14 2003-06-30 Smithkline Beecham Corporation Compounds and methods
JP2003281388A (ja) * 2002-03-25 2003-10-03 Hitachi Ltd 自動取引装置
WO2003083068A2 (en) * 2002-03-27 2003-10-09 Smithkline Beecham Corporation Compounds and methods
US20040116490A1 (en) * 2002-03-28 2004-06-17 Marino Jr. Joseph P. Compounds and methods

Similar Documents

Publication Publication Date Title
JP2004520292A5 (enExample)
RU2006127575A (ru) Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2019077725A5 (enExample)
JP2020516671A5 (enExample)
JP2007523181A5 (enExample)
JP2005511608A5 (enExample)
US20090054491A1 (en) Use
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2010505809A5 (enExample)
JP2009519965A5 (enExample)
JP2007523182A5 (enExample)
RU2004117545A (ru) Аминопиримидины и пиридины
JP2007511485A5 (enExample)
JP2006524686A5 (enExample)
RU2009111113A (ru) Мидуляторы mglur5
JP2006506380A5 (enExample)
JP2006507355A5 (enExample)
JP2005509632A5 (enExample)
JP2011527675A5 (enExample)
JP2002505286A5 (enExample)
JP2004525184A5 (enExample)
JP2004524279A5 (enExample)
JP2009503103A (ja) アリールピリジン及びその使用方法
JP2004520424A5 (enExample)
CA2465757A1 (en) Triazole derivatives as cyclooxygenase (cox) inhibitors